Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
2 raisons identifiées
Auteur de référence en rhumatologie
22 articles scientifiques publiés — un praticien à la pointe de la recherche
Délais de RDV courts dans la région
78.3 rhumatos / 100 000 hab. — département bien doté
✨ Génération du profil synthétique IA en cours…
CABINET DU DR KENZA BERKACHE-KHOUAS
2 RUE ARTHUR RIMBAUD, 93140 BONDY
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Journal of medical microbiology · 2006
A prospective study was carried out to elucidate the clinical, epidemiological and laboratory features of human brucellosis. A total of 26 948 blood samples (from adults aged 15 years and above) were screened for serological evidence of brucellosis over a period of 16 years. The slide agglutination/Rose Bengal plate agglutination test gave positive results in 517 patients, of which 509 had detectable titres by the standard tube agglutination test (SAT). The diagnosis of brucellosis was documented in 495 (1.8 %) patients based on diagnostic titres (⩾1 : 160, 490 cases) and rising titres from insignificant titres (four cases) by serology and for one case by blood-culture isolation alone. Blood cultures were carried out in 345 cases, of which 191 cases (55.3 %) yieldedBrucella melitensis. In 77/79 cases undertaken for follow up, there was a steady fall in 2-mercaptoethanol (2ME) agglutination titres along with clinical improvement (P<0.01). SAT titres remained detectable in most cases for a longer period in spite of an effective antimicrobial therapy and clinical recovery. A substantial number of patients (84.2 %) presented with fever, this being the only complaint in 51.1 % of the cases. Complications were present in 8.8 % of the patients (arthritis excluded): this included the unusual complications of hydrocele (two cases), Stevens–Johnson syndrome (one case) and urinary tract infection (one case).Brucellaagglutinins were demonstrated in synovial, testicular, hydrocele and cerebrospinal fluids. There was no clinical suspicion of brucellosis in 439 cases (88.7 %) and the diagnosis was made only by routine serology. A two-drug regimen for 42–84 days with a follow-up 2ME test resulted in lower levels of relapse. These results suggest that, in endemic areas of the world, it should be mandatory to screen routinely for brucellosis due to protean clinical manifestations.
Pharmacogenetics and genomics · 2009
Journal of clinical and diagnostic research : JCDR · 2013
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Bioinformation · 2025 · Journal Article
G N, M SSL, V S, K S, et al.
Irish journal of medical science · 2025 · Journal Article
Parthasarathy B, K K, Selvam SP
Bioinformation · 2025 · Journal Article
Ari G, Mohit J, Vilas K, K T, et al.
Cureus · 2023 · Case Reports
K M B, Gulla V, K R, Koneru S, et al.
Travel medicine and infectious disease · 2023 · Observational Study
Jeyaraman N, Jeyaraman M, Nallakumarasamy A, K S, et al.
The spine journal : official journal of the North American Spine Society · 2021 · Journal Article
Rajasekaran S, Soundararajan DCR, Tangavel C, Nayagam SM, et al.
PloS one · 2020 · Journal Article
Desai G, T S J, G SK, L M, et al.
Journal of clinical and diagnostic research : JCDR · 2013 · Journal Article
Vs K, K P, Ramesh M, Venkatesan V
Journal of medical microbiology · 2006 · Journal Article
Mantur BG, Biradar MS, Bidri RC, Mulimani MS, et al.
Global epidemiology · 2026 · Journal Article
Chaimaa A, Ali FH, Radouane B, Kenza H
Cureus · 2026 · Journal Article
Kerketta AH, Rathod AP, Nagori J, Bhagat PR, et al.
Cureus · 2026 · Journal Article
R GS, K N
Cureus · 2025 · Case Reports
K A, Kumar S, M V B, Ramadurai S, et al.
The Pan African medical journal · 2022 · Case Reports
Benhamou RA, Kharbouch M, Tazi H, Basri Z, et al.
Journal of neurosciences in rural practice · 2021 · Journal Article
Unni C, Pettakkandy V, P AJ, Soren SK, et al.
Cureus · 2025 · Case Reports
K R, J P, R R, B V MM, et al.
Cureus · 2024 · Case Reports
Pandian U, K A, Rajesh Lenin R, Dev A, et al.
MethodsX · 2025 · Journal Article
Srivastava S, Nair A, U DKK, Kovela RK, et al.
Pharmacogenetics and genomics · 2009 · Journal Article
Sharma S, Das M, Kumar A, Marwaha V, et al.
Cureus · 2025 · Journal Article
Suyambulingam A, K A, Jayakaran V, Venkatesan A, et al.
MethodsX · 2025 · Journal Article
Srivastava S, Nair A, U DKK, Kovela RK, et al.
Ocular immunology and inflammation · 2024 · Journal Article
Dutta Majumder P, Agarwal S, Shah M, Srinivasan B, et al.
Current environmental health reports · 2022 · Journal Article
Imane S, Oumaima B, Kenza K, Laila I, et al.
Journal of neurosciences in rural practice · 2021 · Journal Article
Unni C, Pettakkandy V, P AJ, Soren SK, et al.